To explore the application of standardized metabolic disease management module in closed-loop management of the subjects from insulin clinical trial under normal epidemic prevention and control

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400079950

Enrollment

Unknown

Registered

2024-01-17

Start date

2024-01-20

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

Experimental group :MMC management was performed on patients, and the following four items were completed during the whole trial process (recruitment, screening, visit, and end). The observational ind

Control Group:General outpatient management

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) All participants in selected insulin clinical trials. (2) The ability to use mobile apps and communicate online.

Exclusion criteria

Exclusion criteria: (1) Behavioral ability judged by the researcher to be insufficient to complete the study. (2) Subjects who discontinue or withdraw from clinical trials.

Design outcomes

Primary

Measure	Time frame
Insulin injection compliance;	—

Countries

China

Contacts

Public ContactNing Zhang

Beijing Luhe Hospital, Capital Medical University

zning-1986@163.com+86 136 0135 4101

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026